ClinVar Miner

Submissions for variant NM_172056.2(KCNH2):c.1918T>C (p.Phe640Leu) (rs199473529)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000182036 SCV000234339 pathogenic not provided 2014-09-23 criteria provided, single submitter clinical testing p.Phe640Leu (TTC>CTC): c.1918 T>C in exon 7 of the KCNH2 gene (NM_000238.2). The F640L mutation in the KCNH2 gene has been reported in association with LQTS (Jongbloed et. al., 1999; Kapa et. al., 2009; Giudicessi et. al., 2012). Jongbloed et. al. (1999) initially identified the F640L amino acid substitution (resulting from a different nucleotide substitution, c.1920 C>A) in one Dutch individual of Surinam background diagnosed with LQT2. The F640L mutation (also resulting from a different nucleotide substitution, c.1920 C>A) was subsequently reported as pathogenic in one individual referred for LQTS genetic testing and was absent from 2600 control alleles (Kapa et. al., 2009; Giudicessi et. al., 2012). The F640L mutation is located in the helical transmembrane domain at a residue that is highly conserved across species. Mutations in this same amino acid residue (F640V) and in nearby residues (K638E, K638N, S641F, I642M) have been reported in association with LQTS, further supporting the functional importance of this residue and this region of the protein. Furthermore, the F640L mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, F640L in the KCNH2 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s).
Center for Human Genetics and Laboratory Diagnostics, Dr. Klein, Dr. Rost and Colleagues RCV000678951 SCV000805166 uncertain significance Long QT syndrome 2 2018-04-25 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.